Sign in
4

Changes in Ownership

BIOGEN INC. Filed Acc 0001127602-25-003957

Head of Pharm Ops and Tech gave up 1,223 shares (to pay taxes)

  • Head of Pharm Ops and Tech acquired 4,042 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Murphy Nicole · Head of Pharm Ops and Tech

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2025-02-07 Exercise or conversion : show line 1 in the form +2,102 11,736.37 D
2025-02-07 Shares withheld for taxes : show line 2 in the form −620 $141.35 $87,637 11,116.37 D
2025-02-07 Exercise or conversion : show line 3 in the form +1,940 13,056.37 D
2025-02-07 Shares withheld for taxes : show line 4 in the form −603 $141.35 $85,234 12,453.37 D

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2025-02-06 Grant or award : show line 5 in the form Restricted Stock Unit +14,050 14,050 D
2025-02-07 Exercise or conversion : show line 6 in the form Restricted Stock Unit −2,102 2,102 D
2025-02-07 Exercise or conversion : show line 7 in the form Restricted Stock Unit −1,940 3,880 D
Loading xslF345X05/form4.xml…